🇺🇸 FDA
Pipeline program

700 µg Dexamethasone

206207-008

Phase 3 small_molecule completed

Quick answer

700 µg Dexamethasone for Macular Edema is a Phase 3 program (small_molecule) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Allergan Pharmaceuticals International Limited
Indication
Macular Edema
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials